NEW YORK ( TheStreet) -- CHANGE IN RATINGSAdobe Systems ( ADBE) downgraded at JMP from Market Perform to Underperform, JMP Securities said. $26 price target. Company cut its sales outlook and has exposure to Europe. Acme Packet ( APKT) downgraded at Jefferies to Hold from Buy, Jefferies said. $21 price target. Hesitation by carriers to invest in wireline. Beam ( BEAM) upgraded at Argus from Hold to Buy, Argus said. $74 price target. Company could be a possible takeover target. Choice Hotels ( CHH) upgraded at Baird from Underperform to Neutral, Robert Baird said. $38 price target. Company is returning cash to shareholders and shorts may soon be scrambling to cover. Colony Bankcorp ( CBAN) upgraded to hold at TheStreet Ratings. Rockwell Collins ( COL) downgraded at Goldman to Sell, Goldman Sachs said. Company is facing increased competition and has high exposure to the defense sector. $46 price target. ConocoPhillips ( COP) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Valuation call, based on a $58 price target. Cisco ( CSCO) upgraded at BMO from Market Perform to Outperform, BMO Capital said. $21 price target. Solid, growing cash flow deserves a higher multiple. Citrix Systems ( CTXS) rated new Hold at ThinkEquity. $84 price target. Company faces growth risks in Europe. Coventry Health ( CVH) downgraded at Leerink to Market Perform, Leerink Swann said. Risk/reward is less favorable, ahead of the Supreme Court decision on healthcare reform. Community Health ( CYH) rated new Buy at UBS. $36 price target. Leader in non urban hospital market with a growth track record. Huntington Bancshares ( HBAN) rated new Neutral at JP Morgan. Company still lags in several key metrics. $7 price target. HCA Holdings ( HCA) rated new Buy at UBS. $34 price target. Nation's largest healthcare provider focused on fast growing markets. Huntington Ingalls ( HII) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. $39 price target. Navy demand should remain strong, relative to other areas of defense. Health Management ( HMA) rated new Buy at UBS. $11 price target. Leading hospital operator in fast growing southeast non-urban market. HSN ( HSNI) downgraded at Citigroup to Neutral from Buy, Citigroup said. $42.50 price target. Strong recent performance in shares. LinkedIn ( LNKD) initiated as a sell at TheStreet Ratings.